Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders.
Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders.
复制标题
GM-CSF 和 FMS 参与骨髓疾病缺失 (5q) 的证据。
DOI：
10.1126/science.3484837
复制
发表时间：
1986
期刊：
影响因子：
--
通讯作者：
Sherr,CJ
中科院分区：
文献类型：
--
作者：
LeBeau,MM;Westbrook,CA;Diaz,MO;Larson,RA;Rowley,JD;Gasson,JC;Golde,DW;Sherr,CJ
By in situ chromosomal hybridization, theGM-CSFandFMSgenes were localized to human chromosome 5 at bands q23 to q31, and at band 5q33, respectively. These genes encode proteins involved in the regulation of hematopoiesis, and are located within a chromosome region frequently deleted in patients with neoplastic myeloid disorders. Both genes were deleted in the 5q- chromosome from bone marrow cells of two patients with refractory anemia and a del(5)(q15q33.3). TheGM-CSFgene alone was deleted in a third patient with acute nonlymphocytic leukemia (ANLL) who has a smaller deletion, del(5)(q22q33.1). Leukemia cells from a fourth patient who has ANLL and does not have a del(5q), but who has a rearranged chromosome 5 that is missing bands q31.3 to q33.1 [ins(21;5)(q22;q31.3q33.1)] were used to sublocalize these genes; both genes were present on the rearranged chromosome 5. Thus, the deletion of one or both of these genes may be important in the pathogenesis of myelodysplastic syndromes or of ANLL.
